logo-loader
viewEuropean Gas

European Gas resumes production testing Folschviller 2 well, France

au_europe350_4e9214b46141d.jpg

European Gas (ASX:EPG) has restarted operations in the Lorraine region, France, production testing the Folschviller-2 well, drilled in the Bleue Lorraine Permit.

The well is the first coal bed methane horizontal well drilled in France and has two horizontal drains located in two separate thick coal seams.

Production testing will be carried out over the next few weeks. A dewatering period, typical in coal bed methane wells, will be followed by a gas production period where flow rates and gas quality will be evaluated.

EGL will provide an update on the testing of the Folschviller-2 well at a later date.

European Gas had previously informed of the testing operations carried out on the well to determine coal bed parameters as well as define the lateral extent of the coal beds where the well is completed.

This type of well has been shown to economically produce gas from coal beds in geological conditions similar to the ones existing in the Lorraine Permits of the company.

The gas production test of the Folschviller-2 well will provide technical information for EPL to progress in the confirmation of coal bed methane Lorraine projects and a guide to the next appraisal activities to be conducted.

EGL's recent work programs have not been impacted by the recent changes in the French legislation that prohibit hydraulic fracturing in hydrocarbon projects.

Quick facts: European Gas

Price: - -

ASX:EPG
Market: ASX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tonix Pharmaceuticals CEO talks through recent pre-clinical and clinical...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman sat down with Proactive at the BIO CEO & investor Conference in New York. Lederman says the biopharma company had recently unveiled the pre-clinical results of TNX-801, its live virus horsepox vaccine that prevents...

58 minutes ago

2 min read